What lies in store for the Hutchmed (china) share price?

What lies in store for the Hutchmed (china) share price?

Article image

Economic uncertainty remains a major concern in many industry sectors. For investors in well known companies like Hutchmed (china) (LON:HCM), the question is: where will prices go from here?

Hutchmed (china) is part of an elite club of UK shares which all have market capitalisations in excess of £1 billion. The stock is currently valued at £4,417m

This special group of large-caps has a powerful presence in the investment funds and pension portfolios of millions of savers. So their performance is closely watched.

Over the past 12 months, the Hutchmed (china) share price has seen an absolute move of 18.8%

Bearing in mind that economic turmoil has affected some sectors worse than others, it’s also worth thinking about that performance in the context of the overall market.

On a relative basis, shares in Hutchmed (china) have moved by 5.41% over the past year and by 21.8% over the past six months.

But what now?

Do analysts rate it as a buy, sell or hold?

Regardless of recent performance, the main question for investors is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news is that analysts generally understand the market's biggest businesses better than most, so they are well-placed to make predictions. That shows up in their Buy, Hold and Sell recommendations.

Among the analysts covering Hutchmed (china), there are currently:

  • 1 Buy recommendations
  • 1 Hold recommendations
  • 0 Sell recommendations

With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.

It's also worth looking at the profile of the stock to understand whether it has strong positive exposure to important factors like Quality, Value and Momentum. On that basis, Stockopedia currently classifies Hutchmed (china) as a momentum trap. You can read more about what that means here.


What does this mean for potential investors?

HUTCHMED (China) is one of the most closely watched shares in the market. But while price trends and broker recommendations can give you an idea about the sentiment around a stock, they can't tell you everything. 

To get a better understanding of the overall investment case, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with HUTCHMED (China) that you can find out about here.


About us

Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.

HUTCHMED (China)'s StockRank™

NeutralSpeculative

HUTCHMED (China)'s StockRank™

With a StockRank of 15, HUTCHMED (China) is in the bottom 15% of the 7,649 stocks we cover in Europe, according to our proprietary ranking system.

See the full StockReport

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.